Endothelial Function in Diabetic Nephropathy

Diabetic nephropathy arises from chronic hyperglycaemia and associated metabolic disturbances that culminate in progressive damage to the glomerular filtration barrier. Endothelial cells lining the glomerular capillaries play a central role in maintaining permselectivity by virtue of their specialised glycocalyx, tight intercellular junctions and production of vasoactive mediators such as nitric oxide. In diabetes, sustained high glucose levels, reactive oxygen species and advanced glycation end-products induce endothelial dysfunction, manifesting as glycocalyx degradation, increased permeability to albumin and dysregulated endothelial-to-mesenchymal transition. This early endothelial injury sets in motion podocyte loss, mesangial expansion and glomerulosclerosis, driving proteinuria and progressive renal impairment. Preservation of endothelial integrity and restoration of the glycocalyx have therefore emerged as key therapeutic objectives. Novel strategies focus on inhibition of glycocalyx-degrading enzymes, antagonism of maladaptive receptor signalling and modulation of oxidative stress. These approaches hold promise for slowing or halting the onset and progression of diabetic kidney disease, with potential global impact given the rising prevalence of diabetes and its associated burden of renal failure.

Research from Nature Portfolio

One foundational study has demonstrated that prophylactic administration of a naturally occurring flavonoid can attenuate early renal injury in diabetic models by suppressing podocyte heparanase expression. Pre-treatment with this compound reduced albuminuria, prevented glomerular basement membrane thickening and oxidative stress, and restored heparan sulphate content in the filtration barrier. Mechanistic investigations revealed that the flavonoid directly inhibits high-glucose-induced activation of the heparanase promoter and downstream enzyme expression in cultured podocytes, thereby preserving the integrity of the glomerular endothelial glycocalyx and reducing protein leakage.

Endothelial Function in Diabetic Nephropathy publication trend

The graph below shows the total number of articles in endothelial function in diabetic nephropathy across all publications each year (not limited to Nature Index journals).

Technical terms

Endothelial glycocalyx: A delicate mesh of glycoproteins and proteoglycans on the luminal surface of endothelial cells that contributes to barrier function and mechanotransduction.

Heparanase: An endoglycosidase that cleaves heparan sulphate chains, leading to glycocalyx degradation and increased vascular permeability.

Glomerular filtration barrier: The tri-layered structure comprising fenestrated endothelium, glomerular basement membrane and podocyte foot processes that regulates plasma ultrafiltration.

Albuminuria: The abnormal presence of albumin in the urine, indicative of compromised glomerular barrier integrity.

Reactive oxygen species (ROS): Highly reactive molecules formed during oxidative metabolism that can damage proteins, lipids and nucleic acids.

Matrix metalloproteinases (MMPs): A family of zinc-dependent proteases that degrade extracellular matrix components, including glycocalyx constituents, under pathophysiological conditions.

References

1. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes. Cardiovascular Diabetology (2024).
2. Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx. JCI Insight (2023).
3. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease. Kidney International (2019).
4. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression. Scientific Reports (2017).